Panamox

Panamox100 mg/5 ml

Oral Suspension


By
MRP 14.7910 % Off
Best PriceTk /
1
Section

Medicine overview

Indications of Panamox 100 mg/5 ml

Panamox 100 mg/5 ml is indicated for the treatment of threadwormswhipwormsroundworms and hookworms.

Theropeutic Class

Anthelmintic

Pharmacology

Panamox 100 mg/5 ml is a synthetic derivative of benzimidazole with a potent anthelmintic activity against the most common nematodes and some cestodes.

Absorption

Parasite immobilization and death occur slowly and clearance from the gastro-intestinal tract may not be completed up to 3 days after administration.

Distribution

The effect of the drug is due to its ability to inhibit glucose uptake irreversibly but it does not affect blood glucose concentration in the host, even in high doses. Panamox 100 mg/5 ml does not necessitate any dosage calculation since the same dosage is used for children and adults.

Metabolism

It can be taken at any time and no special procedures such as purging, use of laxatives and/or dietary changes are required.

Excretion

Parasite immobilization and death occur slowly and clearance from the gastro-intestinal tract may not be completed up to 3 days after administration.

Dosage of Panamox 100 mg/5 ml

Adult and Child over 2 years- Threadworms
Dosage:100 mg or 1 teaspoonful: Single dose
Whipworms, Roundworms, Hookworms
Dosage:100 mg or 1 teaspoonful: Twice daily for 3 days
Notes:If reinfection occurs the second dose may be needed after 2 weeks

Administration of Panamox 100 mg/5 ml

May be taken with or without food.

Interaction of Panamox 100 mg/5 ml

Preliminary evidence suggests that cimetidine inhibits Panamox 100 mg/5 ml metabolism and may result in an increase in plasma concentration.

Contraindications

Panamox 100 mg/5 ml is contraindicated in patients with known hypersensitivity to Panamox 100 mg/5 ml, or to any component of the formulation.

Side Effects of Panamox 100 mg/5 ml

Gastrointestinal: Transient symptoms of abdominal pain and diarrhoea in case of massive infection and expulsion of worms. Hypersensitivity: Rash, urticaria and angioedema have been observed on rare occasions. Central Nervous System: Very rare cases of convulsions have been reported. Haematologic: Neutropenia and agranulocytosis.

Pregnancy & Lactation

Panamox 100 mg/5 ml should not be administered during pregnancy and in women thought to be pregnant. It is not known whether Panamox 100 mg/5 ml or its metabolites are secreted in human breast milk. Thus Panamox 100 mg/5 ml should not be used during lactation unless the potential benefits are considered to outweigh the potential risk associated with treatment.

Precautions & Warnings

General: Periodic assessment of organ system functions, including haematopoietic and hepatic, is advisable during prolonged therapy.Information for Patients: Patients should be informed of the potential risk to the foetus in women taking Panamox 100 mg/5 ml during pregnancy, especially during the first trimester. Patients should also be informed that cleanliness is important to prevent reinfection & transmission of the infection.

Overdose Effects of Panamox 100 mg/5 ml

In the event of accidental overdosage, gastrointestinal complaints lasting up to a few hours may occur. Vomiting and purging should be induced.

Storage Conditions

Store in a cool (Below 25°C temperature) and dry place, protected from light. Keep out of the reach of children.

Drug Classes

Anthelmintic

Mode Of Action

Panamox 100 mg/5 ml is a synthetic broad-spectrum anthelmintic that is active against most nematodes and some other worms. Panamox 100 mg/5 ml is principally used in the treatment of intestinal nematode infection. Panamox 100 mg/5 ml inhibits the formation of the worms' microtubules and causes the worms' glucose depletion. After oral administration about 2-10% of oral dose is absorbed from Gl tract and peak plasma concentration occurs within 30 minutes to 7 hours. Panamox 100 mg/5 ml is highly bound to plasma protein. Elimination half-life is 2.8 to 9 hours.

Pregnancy

Panamox 100 mg/5 ml is not recommended in pregnant women. It is not known whether Panamox 100 mg/5 ml is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when it is administered to a nursing mother.

Pediatric Uses

Paediatric use: The drug has not been extensively studied in children under two years; therefore, in the treatment of children under two years the relative benefit/risk should be considered.

Frequently Asked Questions

What is Panamox 100 mg/5 ml used for?

Mebendazole is indicated for the treatment of threadworms, whipworms, roundworms and hookworms.

What is the dosage of Panamox 100 mg/5 ml?

Adult and Child over 2 years- Threadworms: 100 mg or 1 teaspoonful: Single dose. Whipworms, Roundworms, Hookworms: 100 mg or 1 teaspoonful: Twice daily for 3 days. If reinfection occurs the second dose may be needed after 2 weeks.

What are the side effects of Panamox 100 mg/5 ml?

Gastrointestinal: Transient symptoms of abdominal pain and diarrhoea in case of massive infection and expulsion of worms. Hypersensitivity: Rash, urticaria and angioedema have been observed on rare occasions. Central Nervous System: Very rare cases of convulsions have been reported. Haematologic: Neutropenia and agranulocytosis.

Who should not take Panamox 100 mg/5 ml?

Mebendazole is contraindicated in patients with known hypersensitivity to Mebendazole, or to any component of the formulation.

What precautions should be taken with Panamox 100 mg/5 ml?

General: Periodic assessment of organ system functions, including haematopoietic and hepatic, is advisable during prolonged therapy.Information for Patients: Patients should be informed of the potential risk to the foetus in women taking mebendazole during pregnancy, especially during the first trimester. Patients should also be informed that cleanliness is important to prevent reinfection & trans…

Is Panamox 100 mg/5 ml safe during pregnancy and breastfeeding?

Mebendazole should not be administered during pregnancy and in women thought to be pregnant. It is not known whether mebendazole or its metabolites are secreted in human breast milk. Thus Mebendazole should not be used during lactation unless the potential benefits are considered to outweigh the potential risk associated with treatment.

Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.